Crocetin Enhances Temozolomide Efficacy in Glioblastoma Therapy Through Multiple Pathway Suppression

被引:0
|
作者
Tsai, Wei-En [1 ]
Liu, Yen-Tsen [1 ]
Kuo, Fu-Hsuan [2 ]
Cheng, Wen-Yu [3 ,4 ,5 ,6 ]
Shen, Chiung-Chyi [3 ,4 ,7 ]
Chiao, Ming-Tsang [3 ]
Huang, Yu-Fen [3 ]
Liang, Yea-Jiuen [3 ]
Yang, Yi-Chin [3 ]
Hsieh, Wan-Yu [3 ]
Chen, Jun-Peng [8 ]
Liu, Szu-Yuan [9 ,10 ]
Chiu, Cheng-Di [11 ,12 ]
机构
[1] Taichung Municipal Taichung First Sr High Sch, Taichung, Taiwan
[2] Taichung Vet Hosp, Ctr Geriatr & Gerontol, Taichung 40705, Taiwan
[3] Taichung Vet Gen Hosp, Neurol Inst, Dept Minimally Invas Skull Base Neurosurg, Taichung, Taiwan
[4] Hung Kuang Univ, Dept Phys Therapy, Taichung, Taiwan
[5] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan
[6] Natl Chung Hsing Univ, Coll Med, Dept Postbaccalaureate Med, Taichung, Taiwan
[7] Cent Taiwan Univ Sci & Technol, Basic Med Educ, Taichung, Taiwan
[8] Taichung Vet Gen Hosp, Biostat Task Force, Taichung, Taiwan
[9] Taichung Vet Gen Hosp, Neurol Inst, Dept Neurosurg, Oncol Neurosurg Div, Taichung, Taiwan
[10] Natl Chung Hsing Univ, Grad Inst Life Sci, Coll Life Sci, Dept Life Sci, Taichung, Taiwan
[11] China Med Univ Hosp, Spine Ctr, Taichung, Taiwan
[12] China Med Univ Hosp, Dept Neurosurg, Taichung, Taiwan
关键词
Crocetin; glioblastoma; temozolomide; AKT signaling; cell migration; ACTIVATED PROTEIN-KINASES; MOBILITY GROUP BOX-1; CROCUS-SATIVUS; CELL-MIGRATION; CANCER-CELLS; ENDOTHELIAL-CELLS; GLIOMA CANCER; APOPTOSIS; GROWTH; METASTASIS;
D O I
10.2174/0115672026332275240731054001
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background Glioblastoma multiforme (GBM) is an aggressive type of braintumor that is difficult to remove surgically. Research suggests that substances from saffron, namely crocetin and crocin, could be effective natural treatments, showing abilities to kill cancer cells. Methods Our study focused on evaluating the effects of crocetin on glioma using the U87 cell line. We specifically investigated how crocetin affects the survival, growth, and spread of glioma cells, exploring its impact at concentrations ranging from 75-150 mu M. The study also included experiments combining crocetin with the chemotherapy drug Temozolomide (TMZ) to assess potential synergistic effects. Results Crocetin significantly reduced the viability, proliferation, and migration of glioma cells. It achieved these effects by decreasing the levels of Matrix Metallopeptidase 9 (MMP-9) and Ras homolog family member A (RhoA), proteins that are critical for cancer progression. Additionally, crocetin inhibited the formation of cellular structures necessary for tumor growth. It blocked multiple points of the Ak Strain Transforming (AKT) signaling pathway, which is vital for cancer cell survival. This treatment led to increased cell death and disrupted the cell cycle in the glioma cells. When used in combination with TMZ, crocetin not only enhanced the reduction of cancer cell growth but also promoted cell death and reduced cell replication. This combination therapy further decreased levels of high mobility group box 1 (HMGB1) and Receptor for Advanced Glycation End-products (RAGE), proteins linked to inflammation and tumor progression. It selectively inhibited certain pathways involved in the cellular stress response without affecting others. Conclusion Our results underscore the potential of crocetin as a treatment for glioma. It targets various mechanisms involved in tumor growth and spread, offering multiple avenues for therapy. Further studies are essential to fully understand and utilize crocetin's benefits in treating glioma.
引用
收藏
页码:320 / 336
页数:17
相关论文
共 50 条
  • [41] Resveratrol Enhances the Antitumor Effects of Temozolomide in Glioblastoma via ROS-dependent AMPK-TSC-mTOR Signaling Pathway
    Yuan, Yuan
    Xue, Xue
    Guo, Ruo-Bing
    Sun, Xiu-Lan
    Hu, Gang
    CNS NEUROSCIENCE & THERAPEUTICS, 2012, 18 (07) : 536 - 546
  • [42] PTRF/Cavin-1 enhances chemo-resistance and promotes temozolomide efflux through extracellular vesicles in glioblastoma
    Yang, Eryan
    Wang, Lin
    Jin, Weili
    Liu, Xing
    Wang, Qixue
    Wu, Ye
    Tan, Yanli
    Wang, Yunfei
    Cui, Xiaoteng
    Zhao, Jixing
    Tong, Fei
    Hong, Biao
    Xiao, Menglin
    Liu, Xiaomin
    Fang, Chuan
    Kang, Chunsheng
    THERANOSTICS, 2022, 12 (09): : 4330 - 4347
  • [43] MGMT(P140K) Hematopoietic Stem Cell Gene Therapy Enhances Tolerance and Efficacy of Temozolomide in Combination with O6-benzylguanine in Glioblastoma Patients
    Adair, Jennifer E.
    Mrugala, Maciej M.
    Storer, Barry E.
    Johnston, Sandra K.
    Swanson, Kristin R.
    Kiem, Hans-Peter
    MOLECULAR THERAPY, 2014, 22 : S102 - S103
  • [44] Tramadol attenuates the sensitivity of glioblastoma to temozolomide through the suppression of Cx43-mediated gap junction intercellular communication
    Wang, Lingzhi
    Peng, Yuexia
    Peng, Jianxin
    Shao, Min
    Ma, Li
    Zhu, Zhuoli
    Zhong, Guocheng
    Xia, Zhengyuan
    Huang, Huansen
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2018, 52 (01) : 295 - 304
  • [45] Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma
    Kim, Sang-Soo
    Rait, Antonina
    Kim, Eric
    DeMarco, James
    Pirollo, Kathleen F.
    Chang, Esther H.
    CANCER LETTERS, 2015, 369 (01) : 250 - 258
  • [46] Efficacy and safety of carmustine wafers, followed by radiation, temozolomide, and bevacizumab therapy, for newly diagnosed glioblastoma with maximal resection
    Kanamori, Masayuki
    Shibahara, Ichiyo
    Shimoda, Yoshiteru
    Akiyama, Yukinori
    Beppu, Takaaki
    Ohba, Shigeo
    Enomoto, Toshiyuki
    Ono, Takahiro
    Mitobe, Yuta
    Hanihara, Mitsuto
    Mineharu, Yohei
    Ishida, Joji
    Asano, Kenichiro
    Yoshida, Yasuyuki
    Natsumeda, Manabu
    Nomura, Sadahiro
    Abe, Tatsuya
    Yonezawa, Hajime
    Katakura, Ryuichi
    Shibui, Soichiro
    Kuroiwa, Toshihiko
    Suzuki, Hiroyoshi
    Takei, Hidehiro
    Matsushita, Haruo
    Saito, Ryuta
    Arakawa, Yoshiki
    Sonoda, Yukihiko
    Hirose, Yuichi
    Kumabe, Toshihiro
    Yamaguchi, Takuhiro
    Endo, Hidenori
    Tominaga, Teiji
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2025, 30 (01) : 51 - 61
  • [47] The efficacy and safety of low-dose temozolomide maintenance therapy in elderly patients with glioblastoma: a retrospective cohort study
    Tao, Qingsong
    Zhu, Ting
    Ge, Xiaoqin
    Gong, Shengping
    Guo, Jianxin
    ANNALS OF PALLIATIVE MEDICINE, 2022, : 3513 - 3519
  • [48] GBP2 ENHANCES GLIOBLASTOMA INVASION THROUGH STAT3/FIBRONECTION PATHWAY
    Yu, Shuye
    Li, Ming
    NEURO-ONCOLOGY, 2018, 20 : 47 - 47
  • [49] β-elemene enhances both radiosensitivity and chemosensitivity of glioblastoma cells through the inhibition of the ATM signaling pathway
    Liu, Siwei
    Zhou, Lei
    Zhao, Yongshun
    Yuan, Yuhui
    ONCOLOGY REPORTS, 2015, 34 (02) : 943 - 951
  • [50] Sulforaphene enhances radiosensitivity of hepatocellular carcinoma through suppression of the NF-B pathway
    Ren, Kewei
    Li, Zhen
    Li, Yahua
    Zhang, Wenzhe
    Han, Xinwei
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2017, 31 (08)